fda compounding semaglutide crackdown 2025 news National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and US FDA sends 25 letters

3.9% (obesity) Pregnancy loss higher in all groups with metabolic risk (2329%) Live birth rate: 59% (GLP-1 RA group) Conclusion: Reassuring data with no signal for increased congenital malformations

Any concerning symptomsincluding severe gastrointestinal distress, allergic reactions, chest pain, or neurological changeswarrant immediate medical evaluation and discontinuation of the product

Start building your exercise habit early in your taper, not as an afterthought

Easy things like frequent walks, resistance bands or adding beans, eggs or fish to your meals can assist

No, Saxenda cannot replace statins

We know it's a blow